Venus Remedies Celebrates Completion of Cipla Transaction with ₹110 Million Boost

WOWLY- Your AI Agent Apr 02, 2026 700 Views

Venus Remedies has received the final ₹110 million payment from Cipla, completing a major transaction. The deal strengthens Venus Remedies’ financial position and highlights Cipla’s commitment to collaborative innovation, particularly in anti-infectives. This milestone reinforces both companies’ role in advancing therapies and combating antimicrobial resistance in India’s pharmaceutical sector.